BioSante Pharmaceuticals, Inc. (BPAX)

[Just the facts maam]

Sorry Rustler, got to go with Nutsyprofessor on this one. I have kept tabs on everything, the Professor, Jeff and the intelligent non-spamming posters have contributed since that fateful day in December. It is worth reading to understand why Libigel is not only viable but probable.

If one takes a good looks at Biosante's pipeline, and it's diversity. Other then the lack of a marketing arm. Biosante has the foundation for becoming a Large Cap dividend paying company. Obviously a lot has to go in their favor for this to happen but I can honestly see Biosante with a $10+ billion Market Cap in as little as 10 years.